TAKEDA GMBH

Takeda Pharmaceutical Company in India operates primarily as a pharmaceutical company focused on the commercialization, sales, and distribution of its innovative medicines. It is not primarily a manufacturing factory in India but rather a market-focused entity that brings global pharmaceutical products to the Indian market.

Company Introduction:

Takeda Pharmaceutical Company India Private Limited is the Indian subsidiary of Takeda Pharmaceutical Company Limited, a global, values-based, R&D-driven biopharmaceutical leader headquartered in Japan. Takeda is committed to discovering and delivering life-transforming treatments, guided by its commitment to patients, people, and the planet.

In India, Takeda focuses on addressing unmet medical needs by providing innovative medicines across several therapeutic areas, including:

Rare Diseases: Offering treatments for complex and often life-threatening conditions.

Oncology: Developing and commercializing therapies for various cancers.

Gastroenterology: Providing solutions for digestive health disorders.

Neuroscience: Working on treatments for neurological and psychiatric conditions.

Plasma-Derived Therapies: Supplying essential blood-derived products.

Takeda's presence in India is primarily focused on market access, sales, marketing, medical affairs, and clinical development activities. The company works closely with healthcare professionals, patient organizations, and government bodies to ensure that its innovative therapies reach patients who need them most. While Takeda has a global manufacturing network, its operations in India are centered on bringing these globally manufactured products to the local market and conducting local R&D and commercial activities, rather than operating large-scale production factories for the Indian market under the "Takeda India" entity.

It is important to clarify that Takeda GmbH is the German legal entity of Takeda Pharmaceutical Company. Takeda's operations in India are typically conducted under a distinct entity, such as Takeda Pharmaceutical Company India Private Limited, which is part of the global Takeda network.

Takeda GmbH is a German subsidiary of Takeda Pharmaceutical Company Limited. Takeda's operations and product sales in India are conducted through Takeda Pharmaceutical Company Limited, India Branch, not directly by Takeda GmbH.

Takeda India focuses on innovative medicines across several therapeutic areas. The products typically sold or marketed by Takeda in India include:

Oncology:

NINLARO (ixazomib)

ALUNBRIG (brigatinib)

ICLUSIG (ponatinib)

Gastroenterology:

ENTYVIO (vedolizumab)

Rare Diseases:

ADYNOVATE (antihemophilic factor pegylated)

REPLAGAL (agalsidase alfa)

ELAPRASE (idursulfase)